Stockscreener 앱 받기
5.19
2.37%
0.12
Aethlon Medical Inc 주식(AEMD)의 최신 뉴스
Form 4 Aethlon Medical Inc: Steven P. Larosa (Chief Medical Officer) For: 8 October - Investing.com Nigeria
Form 4 Aethlon Medical Inc: Angela Rossetti (Director) For: 17 April - Investing.com Nigeria
Form 4 Aethlon Medical Inc: Nicolas Gikakis (Director) For: 30 September - Investing.com Nigeria
Form 4 Aethlon Medical Inc: Edward G. Broenniman (Director) For: 30 September By Investing.com - Investing.com South Africa
JANE STREET GROUP, LLC Expands Aethlon Medical Inc (AEMD) Stake with 28,043-Share Purchase - GuruFocus
Jane Street Group Reports 5% Ownership Stake in Aethlon Medical Inc - Kalkine Media
Two Jane Street subsidiaries report stakes in Aethlon Medical (AEMD). - Stock Titan
Aethlon Medical Expands Authorized Common Stock Capacity - The Globe and Mail
Certain Common Stock of Aethlon Medical, Inc. are subject to a Lock-Up Agreement Ending on 6-OCT-2026. - www.marketscreener.com
Aethlon Medical Company Profile & Introduction - Moomoo
Aethlon Medical Corrects 8-K: Preferred Stock Proposal Rejected by Shareholders - Minichart
Form 8K Aethlon Medical Inc For: 1 October By Investing.com - Investing.com Nigeria
Aethlon Medical shareholders approve equity plan amendments and board elections - Investing.com
AEMD: All proposals except preferred stock authorization were approved, with no stockholder questions - TradingView
Aethlon Medical (NasdaqCM:AEMD) Stock Forecast & Analyst Predictions - Simply Wall Street
North Immunology, Aethlon Merge to Advance NOR-101 for AD - Dermatology Times
What Does Aethlon Medical (NASDAQ:AEMD) Reveal About Penny Stocks? - Kalkine Media
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD) - PR Newswire
Aethlon Stock Pulls Back: What's Going On? - Benzinga
Aethlon Medical stock merger with North Immunology, H.C. Wainwright holds neutral - Investing.com
Aethlon Medical Q1 2027 Earnings Call Transcript - Benzinga
Aethlon Stock Pulls Back: What's Going On? - TradingView
Client and Medical Therapeutic Company Aethlon Medical Announces Merger With North Immunology - Procopio
Aethlon Medical To Merge With North Immunology And Raise $180 Million To Advance Atopic Dermatitis Drug NOR-101 - Pulse 2.0
North Immunology to go public via Aethlon reverse merger backed by USD 180m PIPE - AllSci
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Roundup: Orbis Enters $1.4 Billion Partnership with Novo, Dualitas Therapeutics Enters Research collaboration with Roche, Aethlon Medical Merges with North Immunology - Pharmaceutical Executive
Aethlon Medical Shares Surge Over 400% After Announcing North Immunology Merger - Yahoo Finance
North Immunology deal makes Aethlon (NASDAQ: AEMD) a minority owner - Stock Titan
$180 million fuels Aethlon Medical (NASDAQ: AEMD) merger built around a new skin-disease antibody - Stock Titan
Aethlon Medical stock soars over 400% on North Immunology merger deal - Investing.com
Aethlon Medical (AEMD) Announces Merger with North Immunology, M - GuruFocus
Aethlon Medical, Inc. (NASDAQ:AEMD) To Merge With North Immunology; $180M Financing - TradingView
Aethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific Antibody for Atopic Dermatitis - Yahoo Finance
Why Did Aethlon Medical Stock Jump 4X on Thursday?Aethlon Medical (NASDAQ:AEMD) - benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - benzinga.com
AEMD Stock Alert: Halper Sadeh LLC is Investigating Whether Aethlon Medical, Inc. is Obtaining a Fair Price for its Shareholders - Business Wire
Aethlon Medical Stock Short Interest Rises to 65.04% - Quiver Quantitative
Aethlon Medical | DEFA14A: Others - Moomoo
Aethlon Medical (NASDAQ: AEMD) Schedules October 1 Vote on Major Stock Issuance and Equity Plan Expansion - kalkinemedia.com
Aethlon Medical (NASDAQ: AEMD) Confirms 1.6 Million Shares Outstanding After Full Exercise of Pre-Funded Warrants - kalkinemedia.com
Aethlon Medical (AEMD) Drops 18.88% to $2.02: Key Support Level in FocusSocial Sentiment - vinanet.vn
Aethlon Medical (AEMD) Drops 18.88% to $2.02: Key Support Level in FocusStop Loss Guidance - siam.in
Aethlon Medical Completes Warrant Exercises, Clarifying Capitalization - TipRanks
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Aethlon Medical surges as recent clinical progress meets a very small post-split float - Quiver Quantitative
AEMD Stock Slides As Traders Eye Hemopurifier And Q1 Call - StocksToTrade
AEMD Stock Pulls Back As Traders Eye Q1 Earnings And Hemopurifier Focus - timothysykes.com
AEMD Stock Slides As Traders Eye Q1 Results And Conference - StocksToTrade
11.21%
자본화:
|
볼륨(24시간):